Abstract
Aim:
To investigate the pharmacokinetic interactions between zalcitabine and nonsteroidal anti-inflammatory drugs (NSAIDs) in rats.
Methods:
Zalcitabine was administered to rats via an iv injection (20 mg/kg) in the presence or absence of ketoprofen or naproxen (20 mg/kg), and the pharmacokinetic parameters were determined by using non-compartmental analysis.
Results:
Compared with the control (zalcitabine alone), pretreatment with ketoprofen or naproxen 30 min prior to intravenous administration of zalcitabine significantly altered the pharmacokinetic profiles of zalcitabine in rats. Renal clearance of zalcitabine was reduced by approximately 3-4-fold in the presence of ketoprofen or naproxen. Consequently, systemic exposure (AUC) to zalcitabine in the rats pretreated with ketoprofen or naproxen was significantly greater than that for the control group given zalcitabine alone. The terminal plasma half-life of zalcitabine was also prolonged by 4-5-fold in the presence of ketoprofen or naproxen.
Conclusion:
The NSAIDs ketoprofen and naproxen effectively altered the pharmacokinetics of zalcitabine. Therefore, concomitant use of ketoprofen or naproxen in patients being treated with zalcitabine may necessitate close monitoring for potential drug interactions.
Similar content being viewed by others
Article PDF
References
Dahlberg JE, Mitsuya H, Blam SB, Broder S, Aaronson SA . Broad spectrum antiretroviral activity of 2′,3′-dideoxynucleoides. Proc Natl Acad Sci USA 1987; 84: 2469–73.
Ueda K, Tsurimoto T, Nagahata T, Chisaka O, Matsubara K . An in vitro system for screening anti-hepatitis B virus drugs. Virology 1989; 169: 213–6.
Waqar MA, Evans MJ, Manly KF, Hughes RG, Huberman JA . Effects of 2′,3′-dideoxynucleosides on mammalian cells and viruses. J Cell Phys 1984; 121: 402–8.
Barry M, Mulcahy F, Merry C, Gibbons S, Back D . Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection. Clin Pharmacokinet 1999; 36: 289–304.
Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of 2 nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337: 725–33.
Gustavson LE, Fukuda EK, Rubio FA, Dunton AW . A pilot study of the bioavailability and pharmacokinetics of 2′,3′-dideoxycy-tidine in patients with AIDS or AIDS-related complex. J Acquir Immune Defic Synd 1990; 3: 28–31.
Klecker RW Jr, Collins JM, Yarchoan RC, Thomas R, McAtee N, Broder S, et al. Pharmacokinetics of 2′,3′-dideoxycytidine in patients with AIDS and related disorders. J Clin Pharmacol 1988; 28: 837–42.
Gibbs JE, Thomas SA . The distribution of the anti-HIV drug, 2′, 3′-dideoxycytidine (ddC), across the blood-brain and blood-cerebrospinal fluid barriers and the influence of organic anion transport inhibitors. J Neurochem 2002; 80: 392–404.
Wada S, Tsuda M, Sekine T, Cha SH, Kimura M, Kanai Y, et al. Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. J Pharmacol Exp Ther 2000; 294: 844–9.
Burckhardt BC, Burckhardt G . Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 2003; 146: 95–158.
Jariyawat S, Sekine T, Takeda M, Apiwattanakul N, Kanai Y, Sophasan S, et al. The interaction and transport of β-lactam antibiotics with the cloned rat renal organic anion transporter 1. J Pharmacol Exp Ther 1999; 290: 672–7.
Khamdang S, Takeda M, Noshiro R, Narikawa S, Enomoto A, Anzai N, et al. Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 2002; 303: 534–9.
Uwai Y, Saito H, Hashimoto Y, Inui KI . Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1. J Pharmacol Exp Ther 2000; 295: 261–5.
Ibrahim SS, Boudinot FD . Pharmacokinetics of 2′,3′-dideoxycyti-dine in rats: application to interspecies scale-up. J Pharm Pharmacol 1989; 41: 829–34.
van Heeswijk RP, Veldkamp AI, Hoetelmans RM, Mulder JW, Schreij G, Hsu A, et al. The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals. AIDS 1999; 13: F95–F99.
van Praag RM, Weverling GJ, Portegies P, Jurriaans S, Zhou XJ, Turner-Foisy ML, et al. Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. AIDS 2000; 14: 1187–94.
Abel S, Nichols DJ, Brearley CJ, Eve MD . Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide. Br J Clin Pharmacol 2000; 49: 64–71.
Christian CD, Meredith CG, Speeg KV . Cimetidine inhibits renal procainamide clearance. Clin Pharmcol Ther 1984; 36: 221–7.
Cundy KC . Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet 1999; 36: 127–43.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by a grant from the basic research program of Korea Science and Engineering Foundation (R012004-0001001302004).
Rights and permissions
About this article
Cite this article
Oh, Yh., Han, Hk. Altered pharmacokinetics of zalcitabine by concurrent use of NSAIDs in rats. Acta Pharmacol Sin 27, 119–122 (2006). https://doi.org/10.1111/j.1745-7254.2006.00249.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00249.x
Keywords
This article is cited by
-
Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models:Â Increasing the Predictability of Poor Metabolism in Humans
Pharmaceutical Research (2021)
-
Corrosion behavior about tubing steel in environment with high H2S and CO2 content
Journal of Wuhan University of Technology-Mater. Sci. Ed. (2013)
-
Nonlinear flow numerical simulation of low-permeability reservoir
Journal of Central South University (2012)